Translational Development Acquisition Corp. (TDAC)
NASDAQ: TDAC · Real-Time Price · USD
10.41
0.00 (0.00%)
Nov 25, 2025, 4:00 PM EST - Market closed

TDAC Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22
Net Income
4.76-0.07-0.49-0.07
Other Amortization
--0.48-
Other Operating Activities
-5.67-0.12--
Change in Accounts Payable
-0.43-0.450-
Change in Other Net Operating Assets
0.04-0.210-0.08
Operating Cash Flow
-1.3-0.85-0-0.15
Other Investing Activities
-174.23-174.23--
Investing Cash Flow
-174.23-174.23--
Long-Term Debt Issued
-0.41--
Total Debt Issued
0.240.41-0.34
Long-Term Debt Repaid
--0.8--
Net Debt Issued (Repaid)
-0.56-0.39-0.34
Issuance of Common Stock
169.05169.05-0.04
Other Financing Activities
6.866.86--0.23
Financing Cash Flow
175.35175.51-0.15
Net Cash Flow
-0.180.44-00
Levered Free Cash Flow
-0.59-0.290.19-
Unlevered Free Cash Flow
-0.59-0.29-0.29-
Change in Working Capital
-0.39-0.660-0.08
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q